Question 1

Am I eligible for this trial based on my current health and medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD clinical trial (NCT00029614). Contact the study team or your healthcare provider for specific answers.

Question 2

How does atomoxetine compare to other treatments I might consider for my ADHD and substance use?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD clinical trial (NCT00029614). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from taking atomoxetine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD clinical trial (NCT00029614). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will the treatment last, and how often will I need to visit for check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD clinical trial (NCT00029614). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my symptoms don't improve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD clinical trial (NCT00029614). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks involved with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD clinical trial (NCT00029614). Contact the study team or your healthcare provider for specific answers.

What this study is about